| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.005 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.098 | 0.005 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.098 | 0.005 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.005 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.096 | 0.006 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.091 | 0.006 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.007 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.082 | 0.007 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.094 | 0.008 |